Prophylaxis of Gastrointestinal Infections With EcN
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This interventional trial shall investigate the efficacy and tolerance of a suspension with
non-pathogenic probiotic E. coli strain Nissle (EcN) on prophylaxis against gastrointestinal
infections in newborn and infants. ECN-SUSPENSION is a probiotic containing viable E. coli
bacteria of the non-pathogenic Nissle 1917 strain at a concentration of 10exp8 cells per ml.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital San Bartolome
Collaborator:
Instituto de Investigacion de las Alteraciones del Crecimiento, Desarrollo y Enfermedades Metabolicas